Back
Intellia Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
27
NTLA
Intellia Therapeutics
Last Price:
$8.32
Seasonality Move:
19.08%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
The current trend is relatively stagnant and NTLA is experiencing slight buying pressure.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.14 | Buy |
| 20-day SMA: | 8.42 | Sell |
| 50-day SMA: | 8.02 | Buy |
| 200-day SMA: | 12.81 | Sell |
| 8-day EMA: | 8.23 | Buy |
| 20-day EMA: | 8.23 | Buy |
| 50-day EMA: | 8.41 | Sell |
| 200-day EMA: | 12.78 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.75 | Buy |
| Chaikin Money Flow: | 957647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.62 - 9.12) | Sell |
| Bollinger Bands (100): | (7.55 - 10.23) | Sell |
Intellia Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 8.31 while NTLA 8-day simple moving average is 8.14, which is a Buy signal.
-
The stock price of NTLA is 8.31 while Intellia Therapeutics 20-day SMA is 8.42, which makes it a Sell.
-
Intellia Therapeutics 50-day simple moving average is 8.02 while NTLA share price is 8.31, making it a Buy technically.
-
NTLA stock price is 8.31 and Intellia Therapeutics 200-day simple moving average is 12.81, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
27
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $8.31. The Score for NTLA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
860.8M
Price in USD:
8.31
Share Volume:
3.3M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
27
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 8.31 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 8.31 while NTLA 8-day exponential moving average is 8.23, which is a Buy signal.
-
The stock price of NTLA is 8.31 while Intellia Therapeutics 20-day EMA is 8.23, which makes it a Buy.
-
Intellia Therapeutics 50-day exponential moving average is 8.41 while NTLA share price is 8.31, making it a Sell technically.
-
NTLA stock price is 8.31 and Intellia Therapeutics 200-day simple moving average is 12.78, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.09 per share, an increase this year of $1.12 per share, and an increase next year of $0.30 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Intellia Therapeutics is a Sell
-
Intellia Therapeutics Relative Strength Index (RSI) is 50.75, which suggest Intellia Therapeutics is overbought
-
The Bollinger Bands (25) for Intellia Therapeutics is (7.62 - 9.12), which suggest Intellia Therapeutics is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.55 - 10.23), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.